v2.4.0.8
Supplemental Guarantor Condensed Consolidating Financials (Tables)
12 Months Ended
Sep. 28, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Schedule of Supplemental Condensed Consolidating Statement of Operations

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Year Ended September 28, 2013

 

    Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  

Revenues:

         

Product sales

  $ 416,871      $ 1,569,605      $ 477,251      $ (362,836   $ 2,100,891   

Service and other revenues

    326,656        71,718        46,635        (53,621     391,388   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    743,527        1,641,323        523,886        (416,457     2,492,279   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses:

         

Cost of product sales

    212,899        636,679        331,418        (362,836     818,160   

Cost of product sales—amortization of intangible assets

    5,346        298,426        4,123        —          307,895   

Cost of product sales—impairment of intangible assets

    —         —         1,714       —         1,714   

Cost of service and other revenues

    157,391        59,943        39,409        (53,621     203,122   

Research and development

    29,829        157,846        9,971        —          197,646   

Selling and marketing

    77,982        176,041        88,114        —          342,137   

General and administrative

    68,883        123,985        34,812        —          227,680   

Amortization of intangible assets

    3,013        104,778        4,806        —          112,597   

Contingent consideration—compensation expense

    80,010        —          —          —          80,010   

Contingent consideration—fair value adjustments

    11,310        —          —          —          11,310   

Impairment of goodwill

    —          1,117,369        —          —          1,117,369   

Gain on sale of intellectual property

    —          (53,884     —          —          (53,884

Restructuring and divestiture charges

    4,889        21,647        6,269        —          32,805   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    651,552        2,642,830        520,636        (416,457     3,398,561   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from operations

    91,975        (1,001,507     3,250        —          (906,282

Interest income

    590        251        461        —          1,302   

Interest expense

    (277,771     (1,260     (2,044     —          (281,075

Debt extinguishment loss

    (9,209     —              (9,209

Other income (expense), net

    193,254        (184,564     (6,387     —          2,303   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

    (1,161     (1,187,080     (4,720     —          (1,192,961

Provision (benefit) for income taxes

    30,794        (59,260     8,343        —          (20,123

Equity in earnings (losses) of subsidiaries

    (1,140,883     13,887        —          1,126,996        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income

  $ (1,172,838   $ (1,113,933   $ (13,063   $ 1,126,996      $ (1,172,838
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Year Ended September 29, 2012

 

    Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  

Revenues:

         

Product sales

  $ 420,960      $ 1,089,580      $ 431,689      $ (284,501   $ 1,657,728   

Service and other revenues

    307,097        63,313        32,555        (58,041     344,924   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    728,057        1,152,893        464,244        (342,542     2,002,652   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses:

         

Cost of product sales

    211,665        396,747        292,928        (284,501     616,839   

Cost of product sales—amortization of intangible assets

    5,226        192,377        4,261        —         201,864   

Cost of service and other revenues

    155,555        61,285        30,713        (58,041     189,512   

Research and development

    28,065        91,199        11,698        —         130,962   

Selling and marketing

    67,874        170,422        84,018        —         322,314   

General and administrative

    52,568        136,243        31,683        —         220,494   

Amortization of intangible assets

    2,709        64,357        4,970        —         72,036   

Contingent consideration—compensation expense

    81,031        —         —         —         81,031   

Contingent consideration—fair value adjustments

    38,466        —         —         —         38,466   

Impairment of goodwill

    —         5,826        —         —         5,826   

Gain on sale of intellectual property

    —         (12,424     —         —         (12,424

Acquired in-process research and development

    —         4,500        —         —         4,500   

Restructuring and divestiture charges

    49        16,185        1,281        —         17,515   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    643,208        1,126,717        461,552        (342,542     1,888,935   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

    84,849        26,176        2,692        —         113,717   

Interest income

    1,950        159        840        (609     2,340   

Interest expense

    (137,190     (1,158     (1,939     —         (140,287

Debt extinguishment loss

    (42,347     —         —         —         (42,347

Other income, net

    3,051        699        557        609        4,916   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income before income taxes

    (89,687     25,876        2,150        —         (61,661

Provision (benefit) for income taxes

    9,721        (3,094     5,346        —         11,973   

Equity in earnings (losses) of subsidiaries

    25,774        8,415        556        (34,745     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income

  $ (73,634   $ 37,385      $ (2,640   $ (34,745   $ (73,634
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Year Ended September 24, 2011

 

    Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  

Revenues:

         

Product sales

  $ 411,309      $ 964,584      $ 376,575      $ (274,128   $ 1,478,340   

Service and other revenues

    274,197        59,026        27,862        (50,076     311,009   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    685,506        1,023,610        404,437        (324,204     1,789,349   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses:

         

Cost of product sales

    200,912        309,910        284,495        (274,128     521,189   

Cost of product sales—amortization of intangible assets

    5,224        167,341        4,891        —         177,456   

Cost of service and other revenues

    143,399        51,888        22,312        (50,076     167,523   

Research and development

    28,959        75,437        12,300        —         116,696   

Selling and marketing

    60,496        166,458        59,776        —         286,730   

General and administrative

    50,180        86,270        23,113        —         159,563   

Amortization of intangible assets

    2,709        54,851        774        —         58,334   

Contingent consideration—compensation expense

    20,002        —         —         —         20,002   

Contingent consideration—fair value adjustments

    (8,016     —         —         —         (8,016

Gain on sale of intellectual property

    —         (84,502     —         —         (84,502

Restructuring and divestiture charges

    (353     —         282        —         (71
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    503,512        827,653        407,943        (324,204     1,414,904   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from operations

    181,994        195,957        (3,506     —         374,445   

Interest income

    1,495        1        364        —         1,860   

Interest expense

    (111,583     (1,357     (1,906     —         (114,846

Debt extinguishment loss

    (29,891     —         —         —         (29,891

Other (expense) income, net

    (1,706     (2,661     185        —         (4,182
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

    40,309        191,940        (4,863     —         227,386   

Provision (benefit) for income taxes

    10,976        60,163        (903     —         70,236   

Equity in earnings (losses) of subsidiaries

    127,817        8,699        319        (136,835     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

  $ 157,150      $ 140,476      $ (3,641   $ (136,835   $ 157,150   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
Schedule of Supplemental Condensed Consolidating Statements of Comprehensive (Loss) Income

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

For the Year Ended September 28, 2013

 

     Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations      Consolidated  

Net (loss) income

   $ (1,172,838   $ (1,113,933   $ (13,063   $ 1,126,996      $ (1,172,838

Foreign currency cumulative translation adjustment

     —         658        715        —          1,373   

Adjustment to minimum pension liability, net of taxes

     —          —          134        —           134   

Unrealized gain on available-for-sale securities

     —         12,094        —         —          12,094   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Comprehensive (loss) income

   $ (1,172,838   $ (1,101,181   $ (12,214   $ 1,126,996       $ (1,159,237
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

For the Year Ended September 29, 2012

 

     Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  

Net (loss) income

   $ (73,634   $ 37,385      $ (2,640   $ (34,745   $ (73,634

Foreign currency translation adjustment

     836        (527     5,908        —         6,217   

Adjustment to minimum pension liability, net of taxes

     —         —         (1,484     —         (1,484

Unrealized gain on available-for-sale security, net of taxes

     —         62        —         —         62   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss)

     836        (465     4,424        —         4,795   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive (loss) income

   $ (72,798   $ 36,920      $ 1,784      $ (34,745   $ (68,839
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

For the Year Ended September 24, 2011

 

     Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  

Net income (loss)

   $ 157,150      $ 140,476      $ (3,641   $ (136,835   $ 157,150   

Foreign currency translation adjustment

     (1,127     (121     2,336        —         1,088   

Adjustment to minimum pension liability, net of taxes

     —         —         764        —         764   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss)

     (1,127     (121     3,100        —         1,852   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income (loss)

   $ 156,023      $ 140,355      $ (541   $ (136,835   $ 159,002   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
Schedule of Supplemental Condensed Consolidating Balance Sheet

SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET

September 28, 2013

 

    Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  
ASSETS          

Current assets:

         

Cash and cash equivalents

  $ 321,523      $ 387,422      $ 113,545      $ —       $ 822,490   

Restricted cash

    —         —         6,914        —         6,914  

Accounts receivable, net

    126,036        174,433        108,804        —          409,273   

Inventories

    81,924        146,678        60,761        —          289,363   

Deferred income tax assets

    —         19,042       494       (19,536 )     —    

Prepaid income taxes

    47,131        2,303        —          (4,689     44,745   

Prepaid expenses and other current assets

    16,246        21,112        11,003        —          48,361   

Other current assets—assets held for sale

    —          —          2,997        —          2,997   

Intercompany receivables

    —         2,442,502       31,949       (2,474,451 )     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current assets

    592,860        3,193,492        336,467        (2,498,676     1,624,143   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Property, plant and equipment, net

    29,313        356,736        105,479        —          491,528   

Intangible assets, net

    19,925        3,784,987        101,810        —          3,906,722   

Goodwill

    283,038        2,390,939        140,551        —          2,814,528   

Other assets

    103,548        58,446        1,908        —          163,902   

Investment in subsidiaries

    8,667,620        129,016        2,296        (8,798,932     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

  $ 9,696,304      $ 9,913,616      $ 688,511      $ (11,297,608   $ 9,000,823   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY          

Current liabilities:

         

Current portion of long-term debt

  $ 563,812      $ —       $ —       $ —       $ 563,812   

Accounts payable

    27,865        42,661        10,008        —          80,534   

Accrued expenses

    152,950        79,629        44,319        (4,967     271,931   

Deferred revenue

    93,306        7,958        31,055        —          132,319   

Deferred income tax liabilities

    59,346        —          —          (19,536     39,810   

Intercompany payables

    2,418,089        —          64,411        (2,482,500     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current liabilities

    3,315,368        130,248        149,793        (2,507,003     1,088,406   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Long-term debt, net of current portion

    4,242,098        —          —          —          4,242,098   

Deferred income tax liabilities

    89,085        1,435,522        10,699        —          1,535,306   

Deferred service obligations—long-term

    11,251        3,511        12,864        (2,170     25,456   

Other long-term liabilities

    96,990        37,598        33,456        —          168,044   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total stockholders’ equity

    1,941,512        8,306,737        481,699        (8,788,435     1,941,513   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities and stockholders’ equity

  $ 9,696,304      $ 9,913,616      $ 688,511      $ (11,297,608   $ 9,000,823   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET

September 29, 2012

 

    Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  
ASSETS          

Current assets:

         

Cash and cash equivalents

  $ 210,028      $ 269,416      $ 80,986      $ —       $ 560,430   

Restricted cash

    —         —         5,696        —         5,696   

Accounts receivable, net

    101,538        192,349        115,522        (76     409,333   

Inventories

    74,500        223,043        70,180        (532     367,191   

Deferred income tax assets

    13,578        —         617        (2,480     11,715   

Prepaid income taxes

    20,805        48,429        611        —         69,845   

Prepaid expenses and other current assets

    18,817        12,816        12,668        —         44,301   

Intercompany receivables

    —         2,094,017        55,761        (2,149,778     —    

Other current assets—assets held-for-sale

    —         67,878        26,625        —         94,503   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current assets

    439,266        2,907,948        368,666        (2,152,866     1,563,014   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Property, plant and equipment, net

    26,928        379,702        101,368        —         507,998   

Intangible assets, net

    24,034        4,162,930        114,286        —         4,301,250   

Goodwill

    279,956        3,522,474        140,349        —         3,942,779   

Other assets

    112,339        49,036        2,406        (1,714     162,067   

Investments in subsidiaries

    9,782,940        101,615        2,296        (9,886,851     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

  $ 10,665,463      $ 11,123,705      $ 729,371      $ (12,041,431   $ 10,477,108   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY          

Current liabilities:

         

Current portion of long-term debt

  $ 64,435      $ —       $ —       $ —       $ 64,435   

Accounts payable

    29,847        43,339        14,037        —         87,223   

Accrued expenses

    238,387        86,566        50,052        (2,624     372,381   

Deferred revenue

    92,234        10,307        27,147        —         129,688   

Intercompany payables

    2,085,339        6,655        66,335        (2,158,329     —    

Other current liabilities—assets held-for-sale

    —         5,520        2,102        —         7,622   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current liabilities

    2,510,242        152,387        159,673        (2,160,953     661,349   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Long-term debt, net of current portion

    4,971,179        —         —         —         4,971,179   

Deferred income tax liabilities

    180,916        1,581,833        8,836        —         1,771,585   

Deferred service obligations—long-term

    7,536        1,160        7,601        (2,583     13,714   

Other long-term liabilities

    34,559        30,587        34,504        (1,400     98,250   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total stockholders’ equity

    2,961,031        9,357,738        518,757        (9,876,495     2,961,031   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities and stockholders’ equity

  $ 10,665,463      $ 11,123,705      $ 729,371      $ (12,041,431   $ 10,477,108   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
Schedule of Consolidating Statement of Cash Flows

CONSOLIDATING STATEMENT OF CASH FLOWS

For the Year Ended September 28, 2013

 

    Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  

OPERATING ACTIVITIES

         

Net cash provided by operating activities

  $ 237,354      $ 205,034      $ 51,434      $ —       $ 493,822   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

INVESTING ACTIVITIES

         

Acquisition of businesses

    (6,053     —          (220     —         (6,273

Payment of additional acquisition consideration

    (16,808     —          —          —         (16,808

Proceeds from sale of business, net of cash transferred

    —         83,646       1,488       —         85,134   

Purchase of property and equipment

    (15,480     (23,345     (10,129     —         (48,954

Increase in equipment under customer usage agreements

    (464     (24,443     (16,269     —         (41,176

Purchase of insurance contracts

    (4,000     —          —          —         (4,000

Proceeds from sale of intellectual property

    —          60,000       —         —         60,000  

Purchase of cost-method investments

    (3,500     (225     —          —         (3,725

Sale of cost-method investments

    2,104        —          —          —         2,104   

Investment in subsdiaries

    —          1,812        (1,812     —          —     

Increase in other assets

    (2,097     (4,209     (1,242     —         (7,548
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

    (46,298     93,236        (28,184     —         18,754   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

FINANCING ACTIVITIES

         

Repayment of long-term debt

    (265,000     —         —         —         (265,000

Payment of debt issuance cost

    (9,440           (9,440

Payment of contingent consideration

    (42,958     —         —         —         (42,958

Deferred acquisition consideration

    (1,655     —         —         —         (1,655

Net proceeds from issuance of common stock pursuant to employee stock plans

    75,100        —         —         —         75,100   

Excess tax benefit related to equity awards

    7,439        —         —         —         7,439   

Payment of employee restricted stock minimum tax withholdings

    (12,256     —         —         —         (12,256

Intercompany dividend

    169,209        (175,000     5,791       —         —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in (provided by) financing activities

    (79,561     (175,000     5,791       —         (248,770

Effect of exchange rate changes on cash and cash equivalents

    —         (5,264     3,518        —         (1,746
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase in cash and cash equivalents

    111,495        118,006        32,559        —         262,060   

Cash and cash equivalents, beginning of period

    210,028        269,416        80,986        —         560,430   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of period

  $ 321,523      $ 387,422      $ 113,545      $ —       $ 822,490   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

 

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

For the Year Ended September 29, 2012

 

    Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  

OPERATING ACTIVITIES

         

Net cash provided by operating activities

  $ 236,063      $ 104,167      $ 29,992      $ —       $ 370,222   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

INVESTING ACTIVITIES

         

Acquisition of business, net of cash acquired

    (3,971,970     196,771        12,796        —         (3,762,403

Payment of additional acquisition consideration

    (8,858     —         (926     —         (9,784

Proceeds from sale of intellectual property

    —         12,500        —         —         12,500   

Purchase of property and equipment

    (13,247     (12,444     (7,458     —         (33,149

Increase in equipment under customer usage agreements

    —         (30,735     (14,889     —         (45,624

Acquisition of in-process research and development assets

    (4,500     —         —         —         (4,500

Purchase of cost-method investment

    —         (250     —         —         (250

Increase in other assets

    (558     (2,230     (4,786     —         (7,574
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash (used in) provided by investing activities

    (3,999,133     163,612        (15,263     —         (3,850,784
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

FINANCING ACTIVITIES

         

Proceeds from long-term debt

    3,476,320        —         —         —         3,476,320   

Payment of debt issuance costs

    (81,408     —         —         —         (81,408

Payment of contingent consideration

    (51,680     —         —         —         (51,680

Payment of deferred acquisition consideration

    (44,223     —         —         —         (44,223

Net proceeds from issuance of common stock pursuant to employee stock plans

    28,594        —         —         —         28,594   

Excess tax benefit related to equity awards

    6,206        —         —         —         6,206   

Payment of employee restricted stock minimum tax withholdings

    (5,710     —         —         —         (5,710
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

    3,328,099        —         —         —         3,328,099   

Effect of exchange rate changes on cash and cash equivalents

    302        1,637        (1,378     —         561   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net (decrease) increase in cash and cash equivalents

    (434,669     269,416        13,351        —         (151,902

Cash and cash equivalents, beginning of period

    644,697        —         67,635        —         712,332   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of period

  $ 210,028      $ 269,416      $ 80,986      $ —       $ 560,430   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

For the Year Ended September 24, 2011

 

    Parent/Issuer     Guarantor
Subsidiaries
    Non-Guarantor
Subsidiaries
    Eliminations     Consolidated  

OPERATING ACTIVITIES

         

Net cash provided by operating activities

  $ 431,353      $ 9,040      $ 15,631      $ —       $ 456,024   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

INVESTING ACTIVITIES

         

Acquisition of business, net of cash acquired

    (240,917     9,070        33,103        —         (198,744 )

Payment of additional acquisition consideration

    (19,660     —         —         —         (19,660 )

Divestiture activities, net of cash transferred

    1,138        —         1,129        —         2,267   

Proceeds from sale of intellectual property

    750        12,500        —         —         13,250   

Purchase of property and equipment

    (11,512     (8,646     (7,627     —         (27,785 )

Increase in equipment under customer usage agreements

    (1,121     (17,361     (9,396     —         (27,878 )

Purchase of licensed technology and other intangible assets

    —         (3,021     —         —         (3,021 )

Purchase of insurance contracts

    (5,322     —         —         —         (5,322

Purchase of cost-method investment

    —         (99     —         —         (99 )

Increase in restricted cash

    —         —         405        —         405   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash (used in) provided by investing activities

    (276,644     (7,557     17,614        —         (266,587 )
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

FINANCING ACTIVITIES

         

Repayment of long-term debt and notes payable

    —         (1,362     —         —         (1,362 )

Payment of debt issuance costs

    (5,327     —         —         —         (5,327 )

Payment of contingent consideration

    (4,294     —         —         —         (4,294 )

Net proceeds from issuance of common stock pursuant to employee stock plans

    25,404        —         —         —         25,404   

Excess tax benefit related to equity awards

    3,652        —         —         —         3,652   

Payment of employee restricted stock minimum tax withholdings

    (10,399     —         —         —         (10,399 )
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

    9,036        (1,362     —         —         7,674   

Effect of exchange rate changes on cash and cash equivalents

    48        (121     (331     —         (404 )
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase in cash and cash equivalents

    163,793        —         32,914        —         196,707   

Cash and cash equivalents, beginning of period

    480,904        —         34,721        —         515,625   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of period

  $ 644,697      $ —       $ 67,635      $ —       $ 712,332